3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Lymphoma, Non-Hodgkin
16
Myelodysplastic Syndromes
15
Leukemia, Myeloid, Acute
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Hodgkin Disease
15
Lymphoma, Mantle-Cell
14
Multiple Myeloma
13
Waldenstrom Macroglobulinemia
12
Graft vs Host Disease
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma
11
Leukemia
11
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
10
Sarcoma
9
Myeloproliferative Disorders
9
Burkitt Lymphoma
9
Tuberous Sclerosis
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Primary Myelofibrosis
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms
6
Lymphoma, Large-Cell, Immunoblastic
6
Leukemia, Myelomonocytic, Chronic
6
Congenital Abnormalities
6
Breast Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphangioleiomyomatosis
5
Interventions
Valganciclovir
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Bevacizumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
2
Nivolumab
2
tocilizumab
1
pomalidomide
1
pembrolizumab
1
liposomal doxorubicin
1
emvododstat
1
efineptakin alfa
1
cabozantinib
1
Zidovudine
1
Sunitinib
1
Polymerase Chain Reaction
1
Nelfinavir
1
Maraviroc
1
Lenalidomide
1
Ipilimumab
1
Immunohistochemistry
1
Imatinib Mesylate
1
HhAntag691
1
Gene Expression Profiling
1
Etoposide
1
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
CTLA-4 Antigen
1
Antiretroviral Therapy, Highly Active
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Kaposi
×
Sirolimus
×
Clear all
No trials found.